Medtronic Gets FDA Clearance for Ligament Augmentation Device

June 24, 2022

Medtronic has received the FDA’s 510(k) as well as a Breakthrough Device designation for its LigaPASS 2.0 ligament augmentation system for use in spinal surgeries.

The ligament augmentation technique provides surgeons the ability to stabilize between vertebrae that are collapsed or are at risk of collapsing in adult spinal deformity patients.

The LigaPASS 2.0 system is designed to help prevent a post-operative complication that can lead to early mechanical failure of the surgery.

“Failure reduction strategies, such as ligament augmentation, are likely to become critical techniques in the treatment of this challenging patient population,” said Christopher Ames, director of spinal tumor and spinal deformity surgery at UCSF Medical Center in California.

View today's stories